First-of-a-kind drug approvals continued rise in 2015
WASHINGTON - Approvals for first-of-a-kind drugs climbed higher last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
The Food and Drug Administration approved 45 drugs with never-before-sold ingredients in 2015, edging past the previous year's tally of 41, which had previously been the highest number since 1996.
FDA drug approvals are considered a barometer of industry innovation and the government's efficiency in reviewing new therapies.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Teens recognized as state\'s top future soldiers by Governor Edwards
Coursey Blvd. gardening business vandalized, owner says more than $10,000 in damages
Man arrested accused of injuring prominent realtor in Prairieville
Baton Rouge man treated by President Trump's doctor after medical emergency
Families, veterans pay respects on Memorial Day at Port Hudson National Cemetery